Stevanato Group S.p.A. Stock (NYSE:STVN)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$19.62

52W Range

$16.56 - $34.73

50D Avg

$19.43

200D Avg

$22.88

Market Cap

$5.36B

Avg Vol (3M)

$548.73K

Beta

0.58

Div Yield

$0.06 (0.31%)

STVN Company Profile


Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

IT

Employees

5,635

IPO Date

Jul 16, 2021

Website

STVN Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22
South America--
Asia Pacific--
Europe Middle East And Africa--
North America--

Fiscal year ends in Dec 23 | Currency in EUR

STVN Financial Summary


Dec 23Dec 22Dec 21
Revenue---
Operating Income---
Net Income---
EBITDA---
Basic EPS---
Diluted EPS---

Fiscal year ends in Dec 23 | Currency in EUR

Latest Earnings Call Transcripts


Q3 24Nov 05, 24 | 2:10 PM
Q1 24May 09, 24 | 12:00 AM
Q4 23Mar 07, 24 | 2:41 PM

Peer Comparison


TickerCompany
MMSIMerit Medical Systems, Inc.
XRAYDENTSPLY SIRONA Inc.
COOThe Cooper Companies, Inc.
WSTWest Pharmaceutical Services, Inc.
ATRCAtriCure, Inc.
AKYAAkoya Biosciences, Inc.
ALCAlcon Inc.
RMDResMed Inc.
NVSTEnvista Holdings Corporation
ANGOAngioDynamics, Inc.
HAEHaemonetics Corporation
ICUIICU Medical, Inc.
ATRAptarGroup, Inc.
TFXTeleflex Incorporated